Saturday, Dec 20th
Last update10:11:42 AM GMT
Drug companies are blocking or delaying the entry of cheaper generic medicines into the EU, pushing up medicine bills, the European Commission has said.
Their actions cost EU healthcare providers 3bn euros ($3.9bn; £2.5bn) in savings between 2000 and 2007, it said.
Dr. Kade Goepferd watched the Trump administration's moves on Thursday to ban gender-affirming care for transgender... |
 A California jury on Friday awarded $40m to two women who said Johnson & Johnson’s baby... | ||
 With subsidies for Affordable Care Act (ACA) health insurance set to expire, Americans who rely on... |
 Connecticut, Georgia, Idaho, Massachusetts, Michigan, Rhode Island, South Carolina, Texas and Puerto Rico also saw an... |
